DOCK 8 Antibodies

Santa Cruz Biotechnology features a diverse variety of DOCK 8 monoclonal antibodies for research focused on understanding DOCK 8's role in cellular processes. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DOCK 8, a member of the DOCK family of proteins, plays a crucial role in regulating the actin cytoskeleton and is essential for immune cell function, particularly in T and B lymphocytes. Mutations in the DOCK 8 gene have been linked to immunodeficiency syndromes, highlighting its importance in maintaining a robust immune response. Understanding DOCK 8 function can provide insights into various immunological disorders and potential therapeutic targets. DOCK 8 research has revealed significant implications for immune system development and regulation. Current studies continue to uncover new aspects of DOCK 8's involvement in cellular signaling pathways and immune cell migration. Ongoing research aims to better understand how DOCK 8 dysfunction contributes to various pathological conditions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of DOCK 8's role in human health and disease.